Q-Med AB Deflux Injectable Gel 1ml (x)

Key Features & Benefits Adequately Described

Deflux is a Minimally Invasive Surgery:

VUR is treated with surgically correctable techniques, but with Deflux, the correction can be done with an endoscopic injection, which makes it less invasive.

The procedure can be done on an outpatient basis or in a hospital making recovery quicker than surgical recovery.

Deflux makes an effective non-surgical alternative:

Clinical studies have proven that the use of Deflux decreases BOTH the severity of reflux and set urinary tract infections (UTIs) to repeatable levels.

Most patients after one-time treatment will have long-term benefits with no underlying issues with VUR, thus minimizing the need for antibiotics or other surgical interventions in the long run.

Deflux can be safely used with other Medical devices because of:

The non-animal stabilized hyaluronic acid (NASHA) and dextranomer microspheres used are biocompatible with human bodies as they are gradually metabolized by the body’s systems.

The composition itself poses low allergic reactions or complications thus allowing better tolerability.

Applicable for Various Varying Degrees of VUR Cases:

Deflux is first indicated for Grade II to IV VUR, as it effectively and safely treats mild to moderate cases.

Applicable for both unilateral and bilateral VUR cases.

Quick and Easy Procedure Completion: The endoscopic injection has a duration of 15-30 minutes and is completed with light general anesthesia.

Normal activities can be resumed after 24 hours, making it a preferred treatment for children and caregivers alike.

Effective Duration: The gel that is injected serves as a bulking agent at the ureteral orifice and assists in preventing retrograde ureteral flow.

The gel is gradually incorporated by the body into the surrounding tissue, thus maintaining correction for years.

Criteria for Treatment

Children diagnosed with VUR Grades II to IV.

Recurrent UTIs from reflux bladder dysfunction.

Those in need of replacement for prolonged antibiotic treatment or surgical ureteral reimplantation.

The Process

A cystoscope is used to inject the Deflux gel into the opening of the ureter.

The Dextanomer microspheres are anchored onto position reinforcing the anti-reflux properties of the ureterovesical junction.

The body integrates the microspheres over time, leading to a sustained reduction in VUR.

Contents

1mL Syringe Containing Dextranomer 50mg/mL in a Carrier Gel of Non-Animal Stabilized Hyaluronic Acid
1 Packge Inseert

Item Past Expiration

Conclusion

Deflux Injectable Gel by Q-Med AB is an effective, safe, and minimally invasive treatment for vesicoureteral reflux that clearly stands out when compared to surgical repair. Its ease of use together with the biocompatible materials used, and the high success rates associated with its use make it a preferred device among urologists and pediatric specialists. Deflux enhances patient outcomes and mitigates the risk of urinary tract infections, kidney damage, and long-term antibiotic dependency by addressing reflux-related complications in a timely manner.